{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:31:18Z","timestamp":1775003478881,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":45,"publisher":"Springer US","isbn-type":[{"value":"9781071652176","type":"print"},{"value":"9781071652183","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5218-3_18","type":"book-chapter","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:37:39Z","timestamp":1775000259000},"page":"229-261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treating Immune Thrombotic Thrombocytopenic Purpura with Therapeutic Plasma Exchange"],"prefix":"10.1007","author":[{"given":"Keenan O.","family":"Hogan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Hinojosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Persell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Sosnovske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"18_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1001\/archinte.1925.00120130092009","volume":"36","author":"E Moschcowitz","year":"1925","unstructured":"Moschcowitz E (1925) An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries: an undescribed disease. Arch Intern Med 36:89\u201393","journal-title":"Arch Intern Med"},{"key":"18_CR2","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1182\/blood.V50.3.413.413","volume":"50","author":"RM Bukowski","year":"1977","unstructured":"Bukowski RM, King JW, Hewlett JS (1977) Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura. Blood 50:413\u2013417","journal-title":"Blood"},{"key":"18_CR3","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1056\/NEJM197712222972507","volume":"297","author":"JJ Byrnes","year":"1977","unstructured":"Byrnes JJ, Khurana M (1977) Treatment of thrombotic thrombocytopenic purpura with plasma. N Engl J Med 297:1386\u20131389","journal-title":"N Engl J Med"},{"key":"18_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJM199108083250604","volume":"325","author":"GA Rock","year":"1991","unstructured":"Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325:393\u2013397","journal-title":"N Engl J Med"},{"key":"18_CR5","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","volume":"129","author":"BS Joly","year":"2017","unstructured":"Joly BS, Coppo P, Veyradier A (2017) Thrombotic thrombocytopenic purpura. Blood 129:2836\u20132846","journal-title":"Blood"},{"key":"18_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-3148.2006.00720.x","volume":"17","author":"SJ Brunskill","year":"2007","unstructured":"Brunskill SJ, Tusold A, Benjamin S, Stanworth SJ, Murphy MF (2007) A systematic review of randomized controlled trials for plasma exchange in the treatment of thrombotic thrombocytopenic purpura. Transfus Med 17:17\u201335","journal-title":"Transfus Med"},{"key":"18_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/jca.22043","volume":"38","author":"L Connelly-Smith","year":"2023","unstructured":"Connelly-Smith L, Alquist CR, Aqui NA, Hofmann JC, Klingel R, Onwuemene OA, Patriquin CJ, Pham HP, Sanchez AP, Schneiderman J, Witt V, Zantek ND, Dunbar NM (2023) Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the American Society for Apheresis: the ninth special issue. J Clin Apher 38:77\u2013278","journal-title":"J Clin Apher"},{"key":"18_CR8","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/jca.21643","volume":"33","author":"L Connelly-Smith","year":"2018","unstructured":"Connelly-Smith L, Tanhehco YC, Chhibber V, Delaney M, Eichbaum Q, Fernandez C, Joshi S, Schwartz J, Linenberger M (2018) Choosing wisely for apheresis. J Clin Apher 33:576\u2013579","journal-title":"J Clin Apher"},{"key":"18_CR9","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s00467-007-0549-4","volume":"22","author":"RG Krishnan","year":"2007","unstructured":"Krishnan RG, Coulthard MG (2007) Minimising changes in plasma calcium and magnesium concentrations during plasmapheresis. Pediatr Nephrol 22:1763\u20131766","journal-title":"Pediatr Nephrol"},{"key":"18_CR10","volume-title":"Apheresis: principles and practice. Volume 1: therapeutic apheresis","author":"NM Dunbar","year":"2020","unstructured":"Dunbar NM (2020) Apheresis: principles and practice. Volume 1: therapeutic apheresis, 4th edn. AABB Press, Bethesda, MD","edition":"4"},{"key":"18_CR11","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/jca.21288","volume":"28","author":"KL O'Brien","year":"2013","unstructured":"O'Brien KL, Price TH, Howell C, Delaney M (2013) The use of 50% albumin\/plasma replacement fluid in therapeutic plasma exchange for thrombotic thrombocytopenic purpura. J Clin Apher 28:416\u2013421","journal-title":"J Clin Apher"},{"key":"18_CR12","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/jca.21771","volume":"35","author":"R Hou","year":"2020","unstructured":"Hou R, Tian W, Qiao R, Zhang J (2020) Efficacy of albumin and compounded plasma for plasma exchange in acquired thrombotic thrombocytopenic purpura. J Clin Apher 35:154\u2013162","journal-title":"J Clin Apher"},{"key":"18_CR13","volume-title":"Technical manual","year":"2020","unstructured":"Cohn CS, Delaney M, Johnson ST, Katz LM (eds) (2020) Technical manual, 20th edn. AABB Press, Bethesda, MD","edition":"20"},{"key":"18_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/jca.21336","volume":"29","author":"B Stefanello","year":"2014","unstructured":"Stefanello B, De Paula EV, Orsi FA, Marques JFC Jr, Roveri EG, Colella MP, Ozelo MC, Annichino-Bizzacchi JM, Addas-Carvalho M (2014) Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: a single center retrospective evaluation. J Clin Apher 29:311\u2013315","journal-title":"J Clin Apher"},{"key":"18_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/jca.1003","volume":"16","author":"ZR Ziegler","year":"2001","unstructured":"Ziegler ZR, Shadduck RK, Gryn JF, Rintels PB, George JN, Besa EC, Bodensteiner D, Silver B, Kramer RE (2001) Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenia (TTP). J Clin Apher 16:19\u201322","journal-title":"J Clin Apher"},{"key":"18_CR16","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1182\/bloodadvances.2017005124","volume":"1","author":"EE Page","year":"2017","unstructured":"Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN (2017) Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015. Blood Adv 1:590\u2013600","journal-title":"Blood Adv"},{"key":"18_CR17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1537-2995.2007.01534.x","volume":"48","author":"BM Hawkins","year":"2008","unstructured":"Hawkins BM, Abu-Fadel M, Vesely SK, George JN (2008) Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review. Transfusion 48:382\u2013392","journal-title":"Transfusion"},{"key":"18_CR18","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1016\/S2352-3026(17)30026-1","volume":"4","author":"PK Bendapudi","year":"2017","unstructured":"Bendapudi PK, Hurwitz S, Fry A, Marques MB, Waldo SW, Li A, Sun L, Upadhyay V, Hamdan A, Brunner AM, Gansner JM, Viswanathan S, Kaufman RM, Uhl L, Stowell CP, Dzik WH, Makar RS (2017) Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study. Lancet Haematol 4:e157\u2013e164","journal-title":"Lancet Haematol"},{"key":"18_CR19","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3324\/haematol.2011.049676","volume":"97","author":"Y Benhamou","year":"2012","unstructured":"Benhamou Y, Assi\u00e9 C, Boelle PY, Buffet M, Grillberger R, Malot S, Wynckel A, Presne C, Choukroun G, Poullin P, Prov\u00f4t F, Gruson D, Hamidou M, Bordessoule D, Pourrat J, Mira JP, Le Guern V, Pouteil-Noble C, Daubin C, Vanhille P, Rondeau E, Palcoux JB, Mousson C, Vigneau C, Bonmarchand G, Guidet B, Galicier L, Azoulay E, Rottensteiner H, Veyradier A, Copppo P (2012) Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA reference center experience. Haematologica 97:1181\u20131186","journal-title":"Haematologica"},{"key":"18_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/vox.12050","volume":"105","author":"MJ Bentley","year":"2013","unstructured":"Bentley MJ, Wilson AR, Rodgers GM (2013) Performance of a clinical prediction score for thrombotic thrombocytopenic purpura in an independent cohort. Vox Sang 105:313\u2013318","journal-title":"Vox Sang"},{"key":"18_CR21","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1055\/a-1378-3804","volume":"121","author":"E Mariotte","year":"2021","unstructured":"Mariotte E, Zafrani L, Fadlallah J, Galicier L, Ghrenassia E, Kerhuel L, Calvet L, De Jong A, Lemiale V, Valade S, Joly BS, Stepanian A, Azoulay E, Darmon M (2021) Performance of diagnostic scores in thrombotic microangiopathy patients in the intensive care unit: a monocentric study. Thromb Haemost 121:1427\u20131434","journal-title":"Thromb Haemost"},{"key":"18_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/jca.21347","volume":"30","author":"MM Neyrinck","year":"2015","unstructured":"Neyrinck MM, Vrielink H (2015) Calculations in apheresis. J Clin Apher 30:38\u201342","journal-title":"J Clin Apher"},{"key":"18_CR23","first-page":"164","volume":"5","author":"R Reverberi","year":"2007","unstructured":"Reverberi R, Reverberi L (2007) Removal kinetics of therapeutic apheresis. Blood Transfus 5:164\u2013174","journal-title":"Blood Transfus"},{"key":"18_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1056\/NEJMoa1806311","volume":"380","author":"M Scully","year":"2019","unstructured":"Scully M, Cataland SR, Peyvandi F, Coppo P, Kn\u00f6bl P, Hovinga JAK, Metjian A, de la Rubia J, Pavenski K, Callewaert F, Biswas D, De Winter H, Zeldin RK (2019) Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura. N Engl J Med 380:335\u2013346","journal-title":"N Engl J Med"},{"key":"18_CR25","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1182\/blood-2011-03-341131","volume":"118","author":"M Scully","year":"2011","unstructured":"Scully M, McDonald V, Cavenagh J, Hunt BJ, Longair I, Cohen H, Machin SJ (2011) A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura. Blood 118:1746\u20131753","journal-title":"Blood"},{"key":"18_CR26","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1182\/blood-2005-03-0848","volume":"106","author":"F Fakhouri","year":"2005","unstructured":"Fakhouri F, Vernant JP, Veyradier A, Wolf M, Kaplanski G, Binaut R, Rieger M, Scheiflinger F, Poullin P, Deroure B, Delarue R, Lesavre P, Vanhille P, Hermine O, Remuzzi G, Gr\u00fcnfeld JP (2005) Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases. Blood 106:1932\u20131937","journal-title":"Blood"},{"key":"18_CR27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/jca.21600","volume":"33","author":"MA Mazepa","year":"2018","unstructured":"Mazepa MA, Raval JS, Brecher ME, Park YA (2018) Treatment of acquired thrombotic thrombocytopenic purpura in the U.S. remains heterogeneous: current and future points of clinical equipoise. J Clin Apher 33:291\u2013296","journal-title":"J Clin Apher"},{"key":"18_CR28","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1182\/blood.V126.23.1046.1046","volume":"126","author":"P Chae","year":"2015","unstructured":"Chae P, Raval JS, Liles D, Park YS, Mazepa MA (2015) Plasma exchange taper for acquired TTP is protective against recurrence at both 30 days and 6 months: a retrospective study from 2 academic medical centers. Blood 126:1046","journal-title":"Blood"},{"key":"18_CR29","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/trf.15901","volume":"60","author":"JS Raval","year":"2020","unstructured":"Raval JS, Mazepa MA, Rollins-Raval MA, Kasthuri RS, Park YA (2020) Therapeutic plasma exchange taper does not decrease exacerbations in immune thrombotic thrombocytopenic purpura patients. Transfusion 60:1676\u20131680","journal-title":"Transfusion"},{"key":"18_CR30","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S1081-1206(10)63390-X","volume":"78","author":"GK Kraske","year":"1997","unstructured":"Kraske GK, Shinaberger JH, Klaustermeyer WB (1997) Severe hypersensitivity reaction during hemodialysis. Ann Allergy Asthma Immunol 78:217\u2013220","journal-title":"Ann Allergy Asthma Immunol"},{"key":"18_CR31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1046\/j.1537-2995.1987.27187121484.x","volume":"27","author":"J Dolovich","year":"1987","unstructured":"Dolovich J, Sagona M, Pearson F, Buccholz D, Hiner E, Marshall C (1987) Sensitization of repeat plasmapheresis donors to ethylene oxide gas. Transfusion 27:90\u201393","journal-title":"Transfusion"},{"key":"18_CR32","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1046\/j.1537-2995.1994.341095026976.x","volume":"34","author":"HG Owen","year":"1994","unstructured":"Owen HG, Brecher ME (1994) Atypical reactions associated with use of angiotensin-converting enzyme inhibitors and apheresis. Transfusion 34:891\u2013894","journal-title":"Transfusion"},{"key":"18_CR33","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1111\/trf.17099","volume":"62","author":"SS Kwon","year":"2022","unstructured":"Kwon SS, Kim S, Kim HO (2022) Incidence and characteristics of hypotensive transfusion reaction: 10-year experience in a single center. Transfusion 62:2245\u20132253","journal-title":"Transfusion"},{"key":"18_CR34","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1309\/LMC964NVBLJKBFZC","volume":"44","author":"C Beavers","year":"2013","unstructured":"Beavers C, Flinchum D, Tayyeb Ayyoubi M (2013) Severe intraoperative albumin transfusion reaction and review of the literature. Lab Med 44:e129\u2013e131","journal-title":"Lab Med"},{"key":"18_CR35","doi-asserted-by":"publisher","first-page":"684","DOI":"10.12788\/jhm.3372","volume":"15","author":"MY Lim","year":"2020","unstructured":"Lim MY, Pagano MB, Metcalf RA (2020) Things we do for no reason\u2122: routinely prescribing transfusion premedication to prevent acute transfusion reactions. J Hosp Med 15:684\u2013686","journal-title":"J Hosp Med"},{"key":"18_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tmrv.2006.09.001","volume":"21","author":"TL Geiger","year":"2007","unstructured":"Geiger TL, Howard SC (2007) Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice? Transfus Med Rev 21:1\u201312","journal-title":"Transfus Med Rev"},{"issue":"Suppl. 1","key":"18_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/1744-9987.13814","volume":"26","author":"AP Sanchez","year":"2022","unstructured":"Sanchez AP, Ward DM, Cunard R (2022) Therapeutic plasma exchange in the intensive care unit: rationale, special considerations, and techniques for combined circuits. Ther Apher Dial 26(Suppl. 1):41\u201352","journal-title":"Ther Apher Dial"},{"key":"18_CR38","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/MAT.0000000000000641","volume":"64","author":"RM Sirignano","year":"2018","unstructured":"Sirignano RM, Meyer EK, Fasano R, Paden ML (2018) Pediatric tandem therapeutic apheresis: a multidisciplinary approach. ASAIO J 64:382\u2013388","journal-title":"ASAIO J"},{"key":"18_CR39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/jca.21468","volume":"32","author":"JL Cox","year":"2017","unstructured":"Cox JL, Koepsell SA, Shunkwiler SM (2017) Therapeutic plasma exchange and pregnancy: a case report and guidelines for performing plasma exchange in a pregnant patient. J Clin Apher 32:191\u2013195","journal-title":"J Clin Apher"},{"key":"18_CR40","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/BF00493567","volume":"125","author":"O Linderkamp","year":"1977","unstructured":"Linderkamp O, Versmold HT, Riegel KP, Betke K (1977) Estimation and prediction of blood volume in infants and children. Eur J Pediatr 125:227\u2013234","journal-title":"Eur J Pediatr"},{"key":"18_CR41","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.transci.2016.01.003","volume":"54","author":"M Mortzell Henriksson","year":"2016","unstructured":"Mortzell Henriksson M, Newman E, Witt V, Derfler K, Leitner G, Eloot S, Dhondt A, Deeren D, Rock G, Ptak J, Blaha M, Lanska M, Gasova Z, Hrdlickova R, Ramlow W, Prophet H, Liumbruno G, Mori E, Griskevicius A, Audzijoniene J, Vrielink H, Rombout S, Aandahl A, Sikole A, Tomaz J, Lalic K, Mazic S, Strineholm V, Brink B, Berlin G, Dykes J, Toss F, Axelsson CG, Stegmayr B, Nilsson T, Norda R, Knutson F, Ramsauer B, Wahlstrom A (2016) Adverse events in apheresis: an update of the WAA registry data. Transfus Apher Sci 54:2\u201315","journal-title":"Transfus Apher Sci"},{"key":"18_CR42","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1111\/j.1537-2995.2007.01405.x","volume":"47","author":"B Michon","year":"2007","unstructured":"Michon B, Moghrabi A, Winikoff R, Barrette S, Bernstein ML, Champagne J, David M, Duval M, Hume HA, Robitaille N, B\u00e9lisle A, Champagne MA (2007) Complications of apheresis in children. Transfusion 47:1837\u20131842","journal-title":"Transfusion"},{"key":"18_CR43","first-page":"e1","volume":"21","author":"SR Wilson","year":"2024","unstructured":"Wilson SR, Kasthuri RS (2024) Ambulatory management of thrombotic thrombocytopenia purpura: will we get there? Hema 21:e1\u2013e6","journal-title":"Hema"},{"key":"18_CR44","doi-asserted-by":"publisher","first-page":"11230","DOI":"10.1182\/blood-2022-162837","volume":"140","author":"TA Warr","year":"2022","unstructured":"Warr TA (2022) Caplacizumab treatment, without plasma exchange, of a Jehovah's witness with thrombotic thrombocytopenia purpura resulted in rapid and durable remission: a case report. Blood 140:11230\u201311231","journal-title":"Blood"},{"key":"18_CR45","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1182\/blood-2023-181159","volume":"142","author":"L Kuhne","year":"2023","unstructured":"Kuhne L, Knoebl P, Eller K, Pabinger I, Brinkkoetter PT, V\u00f6lker LA (2023) Management of immune thrombotic thrombocytopenic purpura without therapeutic plasma exchange: analysis of efficacy and safety data. Blood 142:4001","journal-title":"Blood"}],"container-title":["Methods in Molecular Biology","ADAMTS Proteases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5218-3_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:37:41Z","timestamp":1775000261000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5218-3_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071652176","9781071652183"],"references-count":45,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5218-3_18","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 April 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}